Contact
Privacy
DMCA
Robuta
https://pubmed.ncbi.nlm.nih.gov/12020062/
Deramciclane (Egis)
Egis, in collaboration with Orion Pharma and Pharmacia, is developing deramciclane, a 5-HT(2A) antagonist and a 5-HT(2C) inverse agonist, as a potential...
egis